Goc, Jeremy

Publications

Sort by

Co-Author Network

Harnessing Microbiota to Improve Immunotherapy for Gastrointestinal Cancers. Cancer immunology research. 2022 Academic Article GET IT
ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut. 2022 Academic Article
Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer. Cell. 2021 Academic Article GET IT
A circadian clock is essential for homeostasis of group 3 innate lymphoid cells in the gut. Science immunology. 2019 Academic Article GET IT
Times cited: 67
Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2. Nature. 2019 Academic Article GET IT
Times cited: 187
Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients. Journal for immunotherapy of cancer. 2018 Academic Article GET IT
Times cited: 112
Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade. American journal of respiratory and critical care medicine. 2018 Academic Article GET IT
Times cited: 37
Development of Methods for Selective Gene Expression Profiling in Tertiary Lymphoid Structure Using Laser Capture Microdissection. Methods in molecular biology (Clifton, N.J.). 2018 Article GET IT
Lymphoid-Tissue-Resident Commensal Bacteria Promote Members of the IL-10 Cytokine Family to Establish Mutualism. Immunity. 2016 Academic Article GET IT
Times cited: 116

Sort by

Co-investigator Network

Interrogation of a Novel Immuno-Regulatory Pathway in Colitis-Associated Cancer awarded by Crohn''s & Colitis Foundation of America, Inc. Principal Investigator 2017 - 2020

Innate lymphoid cell regulation of the host-microbiota interactions in cancer awarded by National Cancer Institute 2022 - 2027